GlassScriptPhysician profile
Byron Poindexter
NPI 1528177516
$5,378.07
in general payments reported to CMS, 2019-2025
14 companies · $713 in 2025
The $713 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $114 · 2021: $176 · 2022: $1,578 · 2023: $1,845 · 2024: $271 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Consulting Fee: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.44 |
| Consulting Fee | $1,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $2,750.00 | 2022-2023 | Pal |
| Abbvie INC. | $839.41 | 2023-2025 | |
| Galderma Laboratories, L.P. | $785.08 | 2019-2025 | Dysport |
| Allergan, INC. | $375.28 | 2019-2022 | |
| Motiva USA, LLC | $160.33 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $90.64 | 2024-2025 | Exparel |
| Mentor Worldwide LLC | $81.54 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $80.29 | 2024 | Ovitex 2s |
| Acelrx Pharmaceuticals, INC. | $59.94 | 2019-2020 | |
| Merz North America, INC. | $53.17 | 2020-2021 | |
| Heron Therapeutics, INC. | $42.73 | 2023-2024 | Zynrelef |
| Avanos Medical | $27.26 | 2024 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $18.20 | 2019 | |
| Tepha INC | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Poindexter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.